A "reverse pharmacology" approach for developing an anti-malarial phytomedicine.

A "reverse pharmacology" approach to developing an anti-malarial phytomedicine was designed and implemented in Mali, resulting in a new standardized herbal anti-malarial after six years of research. The first step was to select a remedy for development, through a retrospective treatment-ou...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Willcox, M, Graz, B, Falquet, J, Diakite, C, Giani, S, Diallo, D
التنسيق: Journal article
اللغة:English
منشور في: BioMed Central 2011
_version_ 1826269188717543424
author Willcox, M
Graz, B
Falquet, J
Diakite, C
Giani, S
Diallo, D
author_facet Willcox, M
Graz, B
Falquet, J
Diakite, C
Giani, S
Diallo, D
author_sort Willcox, M
collection OXFORD
description A "reverse pharmacology" approach to developing an anti-malarial phytomedicine was designed and implemented in Mali, resulting in a new standardized herbal anti-malarial after six years of research. The first step was to select a remedy for development, through a retrospective treatment-outcome study. The second step was a dose-escalating clinical trial that showed a dose-response phenomenon and helped select the safest and most efficacious dose. The third step was a randomized controlled trial to compare the phytomedicine to the standard first-line treatment. The last step was to identify active compounds which can be used as markers for standardization and quality control. This example of "reverse pharmacology" shows that a standardized phytomedicine can be developed faster and more cheaply than conventional drugs. Even if both approaches are not fully comparable, their efficiency in terms of public health and their complementarity should be thoroughly considered.
first_indexed 2024-03-06T21:21:09Z
format Journal article
id oxford-uuid:417c7a4c-3cc7-4de1-918f-d6d6a9d93078
institution University of Oxford
language English
last_indexed 2024-03-06T21:21:09Z
publishDate 2011
publisher BioMed Central
record_format dspace
spelling oxford-uuid:417c7a4c-3cc7-4de1-918f-d6d6a9d930782022-03-26T14:43:56ZA "reverse pharmacology" approach for developing an anti-malarial phytomedicine.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:417c7a4c-3cc7-4de1-918f-d6d6a9d93078EnglishSymplectic Elements at OxfordBioMed Central2011Willcox, MGraz, BFalquet, JDiakite, CGiani, SDiallo, DA "reverse pharmacology" approach to developing an anti-malarial phytomedicine was designed and implemented in Mali, resulting in a new standardized herbal anti-malarial after six years of research. The first step was to select a remedy for development, through a retrospective treatment-outcome study. The second step was a dose-escalating clinical trial that showed a dose-response phenomenon and helped select the safest and most efficacious dose. The third step was a randomized controlled trial to compare the phytomedicine to the standard first-line treatment. The last step was to identify active compounds which can be used as markers for standardization and quality control. This example of "reverse pharmacology" shows that a standardized phytomedicine can be developed faster and more cheaply than conventional drugs. Even if both approaches are not fully comparable, their efficiency in terms of public health and their complementarity should be thoroughly considered.
spellingShingle Willcox, M
Graz, B
Falquet, J
Diakite, C
Giani, S
Diallo, D
A "reverse pharmacology" approach for developing an anti-malarial phytomedicine.
title A "reverse pharmacology" approach for developing an anti-malarial phytomedicine.
title_full A "reverse pharmacology" approach for developing an anti-malarial phytomedicine.
title_fullStr A "reverse pharmacology" approach for developing an anti-malarial phytomedicine.
title_full_unstemmed A "reverse pharmacology" approach for developing an anti-malarial phytomedicine.
title_short A "reverse pharmacology" approach for developing an anti-malarial phytomedicine.
title_sort reverse pharmacology approach for developing an anti malarial phytomedicine
work_keys_str_mv AT willcoxm areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT grazb areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT falquetj areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT diakitec areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT gianis areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT diallod areversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT willcoxm reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT grazb reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT falquetj reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT diakitec reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT gianis reversepharmacologyapproachfordevelopinganantimalarialphytomedicine
AT diallod reversepharmacologyapproachfordevelopinganantimalarialphytomedicine